MedPath

LINAGLIPTINA/METFORMINA SANDOZ 2,5 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

LINAGLIPTINA/METFORMINA SANDOZ 2,5 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

Pending
Register Number

90042

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Dec 27, 2024

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number90042
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

LINAGLIPTINAActive
Quantity: 2,5 mg
Name: LINAGLIPTINA
METFORMINA HIDROCLORUROActive
Quantity: 1.000 mg
Name: METFORMINA HIDROCLORURO

ATC CLASSIFICATION (3)

A10B
A10BD
A10BD11

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.